{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-090115","form_type":"8-K","ticker":"MOVE","cik":"0001734750","company_name":"Corvex, Inc.","filed_at":"2026-08-14T20:20:32+00:00","discovered_at":"2026-08-14T20:28:21.471209+00:00","generated_at":"2026-08-14T20:28:32.569709+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Corvex Q2 revenue $3.8M, net loss $12.8M; contracted ARR ~$22M","bullets":["Q2 revenue $3.8M vs $103K prior year; net loss $12.8M ($5.12/share) vs $3.2M loss.","Adjusted EBITDA -$3.2M; cash $21.7M; deferred revenue $3.7M.","Contracted annualized revenue on live compute ~$22M as of Aug 14, 2026.","Completed transfer of legacy healthcare assets to lender, extinguishing Bridge Loan, $2.5M gain.","Appointed CFO Chance Moreland, VP Michael Craig; added two board members; simplified capital structure."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-090115","json":"https://secwatch.observer/filing/0001213900-26-090115.json","markdown":"https://secwatch.observer/filing/0001213900-26-090115.md","text":"https://secwatch.observer/filing/0001213900-26-090115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734750/000121390026090115/0001213900-26-090115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734750/000121390026090115/ea0302004-8k_corvex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T20:28:32.569709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}